| Literature DB >> 31701440 |
Georgia Xiromerisiou1, Katerina Dadouli2, Chrysoula Marogianni3, Antonios Provatas3, Panagiotis Ntellas4, Dimitrios Rikos3, Pantelis Stathis5, Despina Georgouli3, Gedeon Loules6, Maria Zamanakou6, Georgios M Hadjigeorgiou7,8.
Abstract
ARSACS is an autosomal recessive disorder characterized by ataxia, spasticity, and polyneuropathy. A plethora of worldwide distributed mutations have been described so far. Here, we report two brothers, born to non-consanguineous parents, presenting with cerebellar ataxia and peripheral neuropathy. Whole-exome sequencing revealed the presence of a novel homozygous variant in the SACS gene. The variant was confirmed by Sanger sequencing and found at heterozygous state in both parents. This is the first reported mutation in this gene, in Greek population. This case report further highlights the growing trend of identifying genetic diseases previously restricted to single, ethnically isolated regions in many different ethnic groups worldwide. Additionally, we performed a systematic review of all published cases with SACs mutations. ARSACS seems to be an important cause of ataxia and many different types of mutations have been identified, mainly located in exon 10. We evaluated the mutation pathogenicity in all previously reported cases to investigate possible phenotype-genotype correlations. We managed to find a correlation between the pathogenicity of mutations, severity of the phenotype, and age of onset of ARSACS. Greater mutation numbers in different populations will be important and mutation-specific functional studies will be essential to identify the pathogenicity of the various ARSACS variants.Entities:
Keywords: ARSACS; Ataxia and polyneuropathy; Autosomal recessive spastic ataxia of Charlevoix-Saguenay; SACS gene; Spastic ataxia
Mesh:
Substances:
Year: 2019 PMID: 31701440 DOI: 10.1007/s12031-019-01410-z
Source DB: PubMed Journal: J Mol Neurosci ISSN: 0895-8696 Impact factor: 3.444